Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...
Italian pharma Alfasigma has penned a 125 million euro ($145 million) deal for the rights to an injectable form of an investigational herpes simplex virus (HSV) encephalitis treatment. | Italian ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...
BabyCenter on MSN
Herpes and pregnancy: What it means for you and your baby
Herpes is common – and manageable. Here's how it can affect pregnancy, birth, and your baby, plus what you can do to protect ...
Over 800 million people have genital herpes — and in many cases the virus can flare up over a person's lifetime, causing painful symptoms. So... Genital herpes infections are very common. There are 42 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback